Glaxosmithline is under fire from shareholders over the “excessive” travel expenses of its chief scientist.

Hal Barron, the drugs giant’s highest-paid executive, received $807,000 (£620,000) in flights and hotels last year.

One major investor said that they were “taken aback” by the “monumentally high” expenses ahead of the company’s AGM next month.

Figures released by GSK show that Dr Barron, a high profile pharmacologist, last year racked up $464,000 worth of flights between his San Francisco home and GSK’s main research hubs in Philadelphia and Stevenage.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s